Skip to main content
Premium Trial:

Request an Annual Quote

Blogging Synthetic Bio

In the latest post at the Omics! Omics! blog, author Keith Robison speaks to the wonders of synthetic biology by pointing out a recent paper published in the online edition of PNAS. A group of biophysicists at UC Berkeley recently constructed a slightly tweaked version of E. coli in an attempt to impart it with the ability to use light to harvest energy. Normally, E. coli doesn't know what to do with light, but this synthetic version, with one gene from another microorganism, can make energy with the right wavelength, according to the blog.


The Scan

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.